Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christine Winchester
New Oral Antithrombotics: Focus on Dabigatran, an Oral, Reversible Direct Thrombin Inhibitor for the Prevention and Treatment of Venous and Arterial Thromboembolic Disorders
Vascular Health and Risk Management
Related publications
Effects of the Oral, Direct Thrombin Inhibitor Dabigatran on Five Common Coagulation Assays
Thrombosis and Haemostasis
Hematology
Oral Anticoagulants in the Treatment of Venous Thromboembolic Complications: Focus on Apixaban
Medical Council
Therapeutic Promise of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor in a Preclinical Model of Colon Carcinogenesis
Clinical and Experimental Pharmacology
Prevention and Treatment of Venous Thromboembolic Disease
Prescriber
Pharmacology
Prevention and Treatment of Venous Thromboembolism With New Oral Anticoagulants: A Practical Update for Clinicians
Thrombosis
Cardiovascular Medicine
Hematology
Cardiology
A Cost-Effectiveness Analysis of Novel Oral Anticoagulants for Primary Prevention of Venous Thromboembolic Disease
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effect of the Oral Thrombin Inhibitor Dabigatran on Allergic Lung Inflammation Induced by Repeated House Dust Mite Administration in Mice
American Journal of Physiology - Lung Cellular and Molecular Physiology
Pulmonary
Respiratory Medicine
Physiology
Cell Biology
The Treatment of Venous Thromboembolism With New Oral Anticoagulants
Italian Journal of Medicine
Medicine
New Oral Anticoagulants for the Treatment of Venous Thromboembolism: Understanding Differences and Similarities
Drugs
Pharmacology
